Draper, Utah, August 4, 2025 – Press Release – Nexus Spine, LLC.
Nexus Spine announces the issuance of a United States patent covering flexible, porous interbody devices (U.S. Patent Number 12,279,967, entitled: “Porous Interbody Spacer”).
“We are pleased to have received this especially impactful patent that we believe has the earliest filing date in the field of flexible, porous, cancellous-matching, interbody products, with the filing date extending back to 2015,” stated David Hawkes, President and Founder of Nexus Spine. David further commented “Bone can only reach an adapted state condition when strained within safe limits. Interbody devices that are too stiff can lead to endplate fracture, formation of fibrous tissue, and delayed segmental stability of up to a year or more. Our patented device addresses these issues.”
Indeed, Nexus Spine believes it holds the leading U.S. patent for porous interbody devices with characteristics requisite for the combination of rapid stability, maintenance of disc height, and preservation of sagittal alignment. The patent includes five independent claims of varying scope, providing broad coverage in the field. On this point, David said “We are thrilled with the amazing breadth of these claims and their varied points of novelty. Our patent attorneys are doing an incredible job. Not only do we have this broad patent now issued, but we also have additional claims pending on this matter to further broaden our coverage.”
Nexus Spine’s recently issued patent includes the following abridged abstract: “Orthopedic implants, particularly interbody spacers, have a combination of correct pore size and stiffness/flexibility. When the implants have the proper pore size and stiffness, osteocytes are able to properly bridge the pores of the implant and then experience a proper compressive load to stimulate the bone cells to form bone within the pores.” Such characteristics allow Nexus Spine’s interbody devices to provide a giant leap forward in patient care.
Nexus Spine continues to develop and invest in advanced technologies, products, and intellectual property portfolios.